Mergers and Acquisitions

Pharmaceutical Executive

Dealmaking in 2016: It’s Complicated

August 25, 2016

Pharm Exec convenes some of the industry’s top business development professionals and negotiators to talk about the current climate for biophamara dealmaking and the critical job of appraising new assets and their potential as market-worthy and transformative products for patients.

Pharmaceutical Executive

Pharm Exec's Anti-Brand of the Year

May 16, 2016

A look at this year’s 2016 Pharm Exec Brand of the Year and it would seem that the industry has much to be optimistic about. But a look at the winner and runner-up for our “Anti-Brand of the Year” award clarifies how many outside of the industry really see it.

Pharmaceutical Executive

Feeling the Heat: Pharm Exec's 2016 Industry Forecast

January 29, 2016

It’s easy to foresee controversy in 2016 as lagging global economic growth and a messy US political slugfest force the pharma industry’s feet to the fire. Can the industry reclaim a semblance of public approval by confronting its pricing demons and focusing on innovation and a fresh, patient-first message?